Moderna Roivant patent deal caps biotech patent fight at $2.25B
TL;DR Summary
Moderna will pay Roivant up to $2.25 billion to settle patent infringement claims over its Covid-19 vaccine, while The Readout highlights Prime Medicine’s gene-therapy work and FDA warnings to telehealth firms over compounded GLP-1s.
- FDA warns more telehealth firms about compounded GLP-1s statnews.com
- FDA sends warning to 30 telehealth companies selling ‘illegal’ GLP-1s The Hill
- US FDA warns 30 telehealth firms over misleading ads for compounded weight‑loss drugs Reuters
- FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters Fierce Pharma
- Independent pharmacy labs, users, push back against FDA’s GLP-1 drug warning Capital Gazette
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
2 min
vs 2 min read
Condensed
91%
361 → 34 words
Want the full story? Read the original article
Read on statnews.com